ESC 365 - Discussion: Aliskiren alone and in combination with enalapril, versus enalapril, in heart failure patients with diabetes.

HFA Premium Access

Discussion: Aliskiren alone and in combination with enalapril, versus enalapril, in heart failure patients with diabetes.

Session: Late Breaking Trials III: Focus on trial updates, registries and meta-analyses

Topic: Miscellaneous

Event: HEART FAILURE 2016

Congress Presentation

11 more presentations in this session

Influenza vaccination and risk of hospitalisation in patients with heart failure: a report from the UK primary and secondary care records.

Speaker: Professor K. Rahimi (Oxford, GB)

Discussion: Influenza vaccination and risk of hospitalisation in patients with heart failure: a report from the UK primary and secondary care records.

Aliskiren alone and in combination with enalapril, versus enalapril, in heart failure patients with diabetes.

Speaker: Professor L. Kober (Copenhagen, DK)

Effect of cardiac resynchronization in patients with diabetes enrolled in echoCRT.

Speaker: Doctor M. Naegele (Zurich, CH)

Discussion: Effect of cardiac resynchronization in patients with diabetes enrolled in echoCRT.

Access the full session

Late Breaking Trials III: Focus on trial updates, registries and meta-analyses

Speakers: Professor K. Rahimi, Professor L. Kober, Doctor M. Naegele

About the event

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress

ESC 365 is supported by